The environment Pharmaceutical companies are operating in is changing fast. Pricing pressures due to value-based care business models, comparative effectiveness research and risk-based pricing, are challenging the industry. Emerging innovations in the area of personalized medicine and precision medicine, the decline in R&D productivity, and the rapidly changing regulatory environment around the globe, require pharmaceutical companies to rethink their current way of creating value from the molecule to the patient – for both branded, generics and biosimilar products.

Key challenges of the industry:

Ready to get Started?